This Research Topic is part of the “New Advances in Electrocochleography for Clinical and Basic Investigation” series.
New Advances in Electrocochleography for Clinical and Basic Investigation
Electrocochleography (ECochG) is an approach for objective measurements of physiologic responses from the inner ear. Measurements have classically been made from electrodes placed in the outer ear canal, on the tympanic membrane, the round window niche, or inside the cochlea. Recent innovations have led to ECochG being used for exciting new purposes that drive clinical practice and contribute to the basic understanding of inner ear physiology. Cochlear implant recording electrodes can monitor the preservation of residual, low-frequency cochlear function, both in the operating room and post-operatively. ECochG measurements can quantify differential effects of inner ear surgery or other manipulations on vestibular and auditory physiology simultaneously. Various attributes of cognitive neuroscience can be addressed with ECochG measurements from the auditory periphery.
These advances in ECochG provide a way to understand a variety of inner ear diseases, hidden hearing loss, and pharmacological therapeutics for the inner ear. ECochG is likely to be of value to improving clinical outcomes for established therapies such as cochlear implants and provide a tool to better understand human hearing and disease.
Manuscripts are sought that inform how ECochG is advancing knowledge of cochlear or vestibular physiology and sensory loss (e.g., cochlear synaptopathy). Also encouraged are papers that demonstrate how ECochG can be used to improve the outcomes of pharmacological therapeutic interventions, and also cochlear implantation. This can include intraoperative monitoring and prediction of the preservation of residual hearing or speech perception. We welcome papers that increase an understanding of the sensory and neural generators of ECochG waveforms and the methods to derive these.
Manuscripts should include a section on the likely utility of the findings (therapeutic or diagnostic), and to advance uptake in the field detail on how the ECochG recordings should be acquired.
Stephen O'Leary - Named on patents lodged by Cochlear Ltd relating to ECochG (electrocochleography). His University receives research grants in the field of ECochG from Cochlear Ltd. these grants are ongoing, Skyler Jennings is a consultant for Frequency Therapeutics.
This Research Topic is part of the “New Advances in Electrocochleography for Clinical and Basic Investigation” series.
New Advances in Electrocochleography for Clinical and Basic Investigation
Electrocochleography (ECochG) is an approach for objective measurements of physiologic responses from the inner ear. Measurements have classically been made from electrodes placed in the outer ear canal, on the tympanic membrane, the round window niche, or inside the cochlea. Recent innovations have led to ECochG being used for exciting new purposes that drive clinical practice and contribute to the basic understanding of inner ear physiology. Cochlear implant recording electrodes can monitor the preservation of residual, low-frequency cochlear function, both in the operating room and post-operatively. ECochG measurements can quantify differential effects of inner ear surgery or other manipulations on vestibular and auditory physiology simultaneously. Various attributes of cognitive neuroscience can be addressed with ECochG measurements from the auditory periphery.
These advances in ECochG provide a way to understand a variety of inner ear diseases, hidden hearing loss, and pharmacological therapeutics for the inner ear. ECochG is likely to be of value to improving clinical outcomes for established therapies such as cochlear implants and provide a tool to better understand human hearing and disease.
Manuscripts are sought that inform how ECochG is advancing knowledge of cochlear or vestibular physiology and sensory loss (e.g., cochlear synaptopathy). Also encouraged are papers that demonstrate how ECochG can be used to improve the outcomes of pharmacological therapeutic interventions, and also cochlear implantation. This can include intraoperative monitoring and prediction of the preservation of residual hearing or speech perception. We welcome papers that increase an understanding of the sensory and neural generators of ECochG waveforms and the methods to derive these.
Manuscripts should include a section on the likely utility of the findings (therapeutic or diagnostic), and to advance uptake in the field detail on how the ECochG recordings should be acquired.
Stephen O'Leary - Named on patents lodged by Cochlear Ltd relating to ECochG (electrocochleography). His University receives research grants in the field of ECochG from Cochlear Ltd. these grants are ongoing, Skyler Jennings is a consultant for Frequency Therapeutics.
